Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03915015 · ClinicalTrials.gov registry record · NA

VAPORHCS/OHSU J: MRI and Devices

A NA study of MRI, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
10,000
Enrollment target
2
Study locations

NCT03915015 is a NA study of MRI that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 10,000 participants, above the 54-participant average among 5 other MRI trials with a reported enrollment target (18419% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03915015, a NA study of MRI, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
10,000 participants
Enrollment target
2
Study locations

Study Summary

This is a database study of clinically indicated MRIs on patients with permanent pacemakers and implantable cardioverter defibrillators.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST MRI

Study Locations (2)

Oregon

  • Oregon Health and Scince University - Portland
  • Portland Veterans Administration Medical Center - Portland

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2012-07-19
Est. Completion 2030-12-31
Phase NA

What the Registry Record Tells You About NCT03915015

The ClinicalTrials.gov registry entry for NCT03915015 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 54-participant average among 5 other MRI trials with a reported enrollment target (18419% higher). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with MRI appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.

NCT03915015 reports 2 study locations spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT03915015 about?

NCT03915015 is a clinical study titled "VAPORHCS/OHSU J: MRI and Devices". This is a database study of clinically indicated MRIs on patients with permanent pacemakers and implantable cardioverter defibrillators.

What is the current status of trial NCT03915015?

This trial is currently recruiting. It is a NA study. The enrollment target is 10,000 participants. The study started on 2012-07-19. Estimated completion is 2030-12-31.

What conditions does trial NCT03915015 study?

This clinical trial studies the following conditions: MRI.

What interventions are being tested in trial NCT03915015?

The interventions under investigation include: MRI (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03915015?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03915015 being conducted?

This trial has 2 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for MRI

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.